Truist Securities Maintains Hold on Nevro, Lowers Price Target to $27
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Richard Newitter maintains a 'Hold' rating on Nevro (NYSE:NVRO) and lowers the price target from $30 to $27.
July 19, 2023 | 3:57 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Truist Securities has maintained a 'Hold' rating on Nevro and lowered the price target from $30 to $27.
The lowering of the price target by Truist Securities from $30 to $27 indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Nevro's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100